Taking a Closer Look at PCSK9 Part 3

As with any new class of medications there are many questions that will need to be answered by and for healthcare professionals. From costs to patient adherence, to overall usage PCSK9 promises to have long lasting effects on the medical community as a whole.

Jennifer Robinson, MD, MPH, from the University of Iowa addressed some of these questions during the American College of Cardiology Annual Scientific Sessions and Expo in San Diego.